{"id":"W3195241595","doi":"10.1016/s0090-8258(21)00656-9","title":"1Rucaparib versus chemotherapy in patients with advanced, relapsed ovarian cancer and a deleterious BRCA mutation: efficacy and safety from ARIEL4, a randomized phase III study","year":2021,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Carboplatin; Gemcitabine; BRCA mutation; Internal medicine; Oncology; Clinical endpoint; Ovarian cancer; Olaparib; Population; PARP inhibitor; Cisplatin; Chemotherapy; Phases of clinical research; Cancer; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003914945,0.0002816731,0.001312688,0.0001065886,0.0001216306,0.00002147291,0.00006569319,0.0002369362,0.0008268187],"category_scores_gemma":[0.0004009664,0.0002272851,0.0000511818,0.0002973636,0.0003295453,0.00009386785,0.00004765504,0.0003513473,0.000002984011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005453692,"about_ca_system_score_gemma":0.000507091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001771834,"about_ca_topic_score_gemma":0.001021479,"domain_scores_codex":[0.9976848,0.0004804335,0.0006043392,0.0006838327,0.0002101227,0.0003364223],"domain_scores_gemma":[0.9972275,0.001846347,0.0002898737,0.0002906049,0.0001883853,0.0001572318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8217267,0.00493645,0.02214957,0.00001948618,0.0008122376,0.0007916568,0.006218839,0.00004147814,0.000420279,0.00005761358,0.00006288454,0.1427628],"study_design_scores_gemma":[0.8644645,0.008193548,0.1229471,0.00005325006,0.0002773833,0.00001998712,0.001003091,0.00008987712,0.0001114229,0.000137374,0.002467338,0.0002351095],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923113,0.0009683241,0.0002229093,0.002211304,0.0005159063,0.00300426,0.00004002094,0.0000602655,0.0006656971],"genre_scores_gemma":[0.9933257,0.0007957604,0.002666991,0.002134335,0.00007906004,0.000734709,0.0001735031,0.00002888325,0.00006105522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1425276,"threshold_uncertainty_score":0.9268416,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01622045015881876,"score_gpt":0.3306101091723185,"score_spread":0.3143896590134998,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}